The global amniotic membrane market is estimated to be valued at US$ 3.62 billion in 2023 and is expected to exhibit a CAGR of 13% during the forecast period (2023-2030).
Analysts’ Views on Global Amniotic Membrane Market:
The amniotic membrane (AM), or amnion, is a thin membrane on the inner side of the fetal placenta; it completely surrounds the embryo and delimits the amniotic cavity, which is filled with amniotic liquid. The rising number of patients with ophthalmology diseases, orthopedic diseases, and surgeries are expected to increase the probability of physicians preferring amniotic membranes for treatment. Thus, it offers the opportunity for various manufacturers to offer innovative amniotic membraine products that allow surgeons to perform such surgeries more efficiently.
Figure 1. Global Amniotic Membrane Market Share (%), By Product Type, 2023
To learn more about this report, Request sample copy
Global Amniotic Membrane Market– Drivers
Increasing Product Launches by the Market Players
On July 26, 2022, Eliksa Therapeutics, a regenerative medicine company, aimed to commercialize multiple regenerative therapeutics based on amniotic fluid and amniotic membrane technologies.
Increasing Research and Development Activities by the Market Players
On September 16, 2022, Théa Pharma Inc., an independent pharmaceutical company, showcased AcellFX, an acellular amniotic membrane, at Vision Expo West.
Figure 2. Global Amniotic Membrane Market Share (%), By Region, 2023
To learn more about this report, Request sample copy
Global Amniotic Membrane Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global amniotic membrane market over the forecast period. North America is estimated to hold 36% of the market share in 2023. The global amniotic membrane market is expected to witness significant growth in the coming years, driven by increasing inorganic strategies by market players. For instance, on November 3, 2022, InfuSystem Holdings, Inc., a healthcare company that provides infusion pumps, and Sanara MedTech Inc., a medical technology company, announced the establishment of a partnership, SI Wound Care, LLC, focused on delivering a complete wound care solution targeted at improving patient outcomes and lowering the cost of care.
Global Amniotic Membrane Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, faced problems with the transportation of things from one place to another.
However, the COVID-19 pandemic had a negative impact on the global amniotic membrane market, owing to widespread lockdowns, elective procedures being cancelled or postponed, and wound care treatments not being provided. In order to reserve or reallocate the limited capacities and resources (such as hospital beds and patient care specialists) towards COVID-19 patient care, elective procedures were being refused (cancelled or postponed). Additionally, many nations implemented curfews and lockdowns to stop the growth in COVID-19 instances. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. The expansion of the market for amniotic products is anticipated to be constrained by this temporary denial of non-emergent healthcare services. However, in the upcoming years, it is anticipated that demand for amniotic membrane products would increase.
Amniotic Membrane Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 3.62 Bn |
Historical Data for: | 2017b to 2021 | Forecast Period: | 2023 to 2030 |
Forecast Period 2023 to 2030 CAGR: | 13% | 2030 Value Projection: | US$ 8.51 Bn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Amniotic Membrane Market Segmentation:
The global amniotic membrane market report is segmented by product type, by application, by end user, and by region.
Among all the segmentation, the application segment is expected to dominate the market over the forecast period, and this is attributed to the increasing prevalence of ophthalmology disease and surgeries globally.
Global Amniotic Membrane Market- Cross Sectional Analysis:
Key players are focusing on organic strategies to increase their footprint in the market, which is expected propel market growth over the forecast period. For instance, on February 28, 2020, Integra LifeSciences, a medical device company, launched the AmnioExcel Plus Placental Allograft Membrane. This product, launched under the company’s wound care portfolio, is designed to aid in the repair of soft tissue.
Global Amniotic Membrane Market: Key Developments
Global Amniotic Membrane Market: Key Trends
Global Amniotic Membrane Market: Restraint
Market players should follow the regulatory guidelines to develop the products.
Global Amniotic Membrane Market - Key Players
Major players operating in the global amniotic membrane market include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical
Global Amniotic Membrane Market– Definition
The innermost layer of the fetal membrane, known as the amniotic membrane, is removed from women's placentas and harvested for use as transplant material in reconstructive surgery for conditions like severely burned skin, trauma wounds, chronic wounds, and others.
Share
About Author
Nikhilesh Ravindra Patel is a Senior Consultant with over 8 years of consulting experience. He excels in market estimations, market insights, and identifying trends and opportunities. His deep understanding of the market dynamics and ability to pinpoint growth areas make him an invaluable asset in guiding clients toward informed business decisions. He plays a instrumental role in providing market intelligence, business intelligence, and competitive intelligence services through the reports.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients